Clinical trial · Observational
Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia
Investigation of the Effects of Anticoagulant/Antiaggregant Use on Postoperative Bleeding Risk in Patients Operated for Bladder Tumor and Benign Prostatic Hyperplasia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Transfusion Complication | — | UNRESOLVED | — |
| Hematuria | — | UNRESOLVED | — |
| Operative Bleeding | — | UNRESOLVED | — |
| Retention, Urinary | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (6)
- label
- TURP patients using anticoagulant/antiaggregant medication
- description
- Patients who used anticoagulant/antiaggregant medication for any reason (eg: coronary artery disease, atrial fibrillation, cerebrovascular disease) before surgery and underwent endoscopic prostatectomy (TURP).
- label
- TURP patients not using anticoagulant/antiaggregant medication
- description
- Patients with no history of anticoagulant/antiaggregant medication and underwent endoscopic prostatectomy (TURP).
- label
- TUR-BT patients using anticoagulant/antiaggregant medication
- description
- Patients who used anticoagulant/antiaggregant medication for any reason (eg: coronary artery disease, atrial fibrillation, cerebrovascular disease) before surgery and underwent endoscopic bladder tumor resection (TUR-BT).
- label
- TUR-BT patients not using anticoagulant/antiaggregant medication
- description
- Patients with no history of anticoagulant/antiaggregant medication and underwent endoscopic bladder tumor resection (TUR-BT).
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing complete endoscopic transurethral tumor resection (TUR-BT) for bladder cancer * Patients undergoing TURP due to benign prostatic hyperplasia * Patients undergoing open prostatectomy due to benign prostatic hyperplasia Exclusion Criteria: * Patients who underwent incomplete transurethral tumor resection for bladder cancer * Patient who underwent TUR biopsy for restaging with no obvious macroscopic tumoral lesion * Patients who underwent cystectomy for bladder cancer
References
Publications (0)
Data not yet available